Work

Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?

Year: 2022

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-22-3229

Authors: Maria A. Velez, Edward B. Garon

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4311578237

FWCI:

Cites: 19

Cited by: 1

Related to: 10